Regenerative Medical Technology Group, Inc. engages in the provision of regenerative stem cell therapy. The company is headquartered in Boca Raton, Florida. The company went IPO on 2001-12-28. GSCG is a provider of regenerative medicine solutions, dedicated to advancing healthcare through patient therapies. The firm operates a portfolio of network of clinics, research facilities, and training centers. The company also distributes stem cells and other regenerative-based cell lines and equipment internationally and specializes in educating and training physicians in the area of regenerative medicine. Its services include certified training courses for physicians, manufacturing and sales of equipment and supplies, research and development of clinical protocols, regenerative medicine clinics for patients, regenerative medicine practitioners’ network, and turnkey stem cell processing center solutions. Through ISSCA, it conducts specialized training, certification, and hands-on workshops.
P/E (price / listing EPS) Forward revenue growth (NTM)